- AU$3.67m
- AU$3.77m
- AU$0.40m
Annual income statement for Opyl, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.626 | 0.768 | 0.902 | 0.618 | 0.398 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 1.75 | 2.2 | 3.35 | 2.95 | 3.62 |
| Operating Profit | -1.12 | -1.43 | -2.44 | -2.33 | -3.23 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.883 | -1.14 | -2.09 | -1.73 | -3.13 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.926 | -1.14 | -2.09 | -1.73 | -3.13 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.926 | -1.14 | -2.09 | -1.73 | -3.13 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.926 | -1.14 | -2.09 | -1.73 | -3.13 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.025 | -0.032 | -0.037 | -0.021 | -0.018 |